{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:08:45Z","timestamp":1790086125656,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Qiagen GmbH"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ijgc-2022-003897","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:26:51Z","timestamp":1674016011000},"page":"669-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct02956031","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7502-2867","authenticated-orcid":false,"given":"Leon Cornelius","family":"Snyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin Louise","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4456-2270","authenticated-orcid":false,"given":"Azwidowi","family":"Lukhwareni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthys Hendrik","family":"Botha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Haynes","family":"Van Der Merwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-460X","authenticated-orcid":false,"given":"Cathy","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-003897_bb0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: Globocan sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0015","author":"Diseases NCRNIoC","year":"2019","journal-title":"Cancer in South Africa 2019 full report National cancer registry"},{"key":"10.1136\/ijgc-2022-003897_bb0020","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2022-003897_bb0025","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/bjc.2016.290","article-title":"Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study","volume":"115","author":"Landy","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(79)90172-7","article-title":"Does screening by \"pap\" smears help prevent cervical cancer? A case-control study","volume":"2","author":"Clarke","year":"1979","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2022-003897_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000365059","article-title":"Benefits and risks of cervical cancer screening","volume":"37 Suppl 3","author":"Petry","year":"2014","journal-title":"Oncol Res Treat"},{"key":"10.1136\/ijgc-2022-003897_bb0040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1136\/ijgc-2022-003897_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2022-003897_bb0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0055","author":"Department of Statistics South Africa","year":"2022"},{"key":"10.1136\/ijgc-2022-003897_bb0060","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/1055-9965.EPI-16-0700","article-title":"A comparison of the natural history of HPV infection and cervical abnormalities among HIV-positive and HIV-negative women in Senegal, Africa","volume":"26","author":"Whitham","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2022-003897_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/LGT.0000000000000090","article-title":"Performance of cervical cancer screening techniques in HIV-infected women in Uganda","volume":"19","author":"Bansil","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"10.1136\/ijgc-2022-003897_bb0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ygyno.2017.11.002","article-title":"Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: findings of initial screening and one-year follow-up","volume":"148","author":"Cholli","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003897_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/bjc.2016.207","article-title":"Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study","volume":"115","author":"Segondy","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0080","article-title":"Primary HPV and molecular cervical cancer screening in US women living with HIV","author":"Strickler","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1136\/ijgc-2022-003897_bb0085","author":"National Department of Health SA","year":"2017","journal-title":"Cervical cancer and control policy"},{"key":"10.1136\/ijgc-2022-003897_bb0090","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7196\/SAMJ.2022.v112i7.16478","article-title":"Phase I of the DiaVACCS screening trial: study design, methods, population demographics and baseline results","volume":"112","author":"Dreyer","year":"2022","journal-title":"S Afr Med J"},{"key":"10.1136\/ijgc-2022-003897_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/JCM.05400-11","article-title":"Comparison of the hybrid capture 2 and COBAS 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium","volume":"50","author":"Wong","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1136\/ijgc-2022-003897_bb0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2757","article-title":"Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review","volume":"342","author":"Rebolj","year":"2011","journal-title":"BMJ"},{"key":"10.1136\/ijgc-2022-003897_bb0110","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/JCM.42.6.2470-2475.2004","article-title":"Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools","volume":"42","author":"Kulmala","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1136\/ijgc-2022-003897_bb0115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"10.1136\/ijgc-2022-003897_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijid.2020.02.051","article-title":"Human papillomavirus prevalence and risk factors among HIV-negative and HIV-positive women residing in rural eastern Cape, South Africa","volume":"95","author":"Taku","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1136\/ijgc-2022-003897_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104445","article-title":"Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon","volume":"128","author":"Adedimeji","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1136\/ijgc-2022-003897_bb0130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7196\/SAMJ.2022.v112i7.16478","article-title":"Phase I of the DiaVACCS screening trial: study design, methods, population demographics and baseline results","volume":"112","author":"Dreyer","year":"2022","journal-title":"S Afr Med J"},{"key":"10.1136\/ijgc-2022-003897_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0956462413491735","article-title":"Incidence and progression of cervical lesions in women with HIV: a systematic global review","volume":"25","author":"Denslow","year":"2014","journal-title":"Int J STD AIDS"},{"key":"10.1136\/ijgc-2022-003897_bb0140","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1136\/ijgc-2022-003897_bb0145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jcv.2013.10.012","article-title":"Influence of HIV-1 and\/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa","volume":"58","author":"Hanisch","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1136\/ijgc-2022-003897_bb0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/kjm2.12175","article-title":"Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China","volume":"36","author":"Zhang","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1136\/ijgc-2022-003897_bb0155","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/ijc.30385","article-title":"Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial","volume":"139","author":"Isidean","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2022-003897_bb0165","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the artistic trial","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2022-003897_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003528","article-title":"Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: a cohort study","volume":"18","author":"Kelly","year":"2021","journal-title":"PLoS Med"},{"key":"10.1136\/ijgc-2022-003897_bb0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/jnci\/92.10.818","article-title":"Human papillomavirus DNA testing for cervical cancer screening in low-resource settings","volume":"92","author":"Kuhn","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2022-003897_bb0180","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1002\/cam4.3329","article-title":"Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women","volume":"9","author":"Johnson","year":"2020","journal-title":"Cancer Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24023971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24023971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-003897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:39:58Z","timestamp":1753101598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24023971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1048891X24023971"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-003897","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-003897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}